[
    [
        {
            "time": "",
            "original_text": "复星医药：复宏汉霖获RX208研发、生产及商业化相关权利许可",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "RX208",
                    "研发",
                    "生产",
                    "商业化"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "复星医药：复宏汉霖获RX208研发、生产及商业化相关权利许可",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "复星医药：控股子公司签署约束性条款书",
            "features": {
                "keywords": [
                    "复星医药",
                    "控股子公司",
                    "约束性条款书"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "复星医药：控股子公司签署约束性条款书",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "复星医药(600196.SH)：复宏汉霖获抗癌药RX208研发、生产及商业化相关权利许可",
            "features": {
                "keywords": [
                    "复星医药",
                    "复宏汉霖",
                    "抗癌药",
                    "RX208",
                    "研发",
                    "生产",
                    "商业化"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "复星医药(600196.SH)：复宏汉霖获抗癌药RX208研发、生产及商业化相关权利许可",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "下周交易提醒：贵州茅台等近500家上市公司披露年报，13只新股连发，限售股解禁市值约338亿元",
            "features": {
                "keywords": [
                    "贵州茅台",
                    "年报披露",
                    "新股发行",
                    "限售股解禁",
                    "市值"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "下周交易提醒：贵州茅台等近500家上市公司披露年报，13只新股连发，限售股解禁市值约338亿元",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]